Literature DB >> 22236881

Urinary survivin mRNA expression and urinary nuclear matrix protein 22 BladderChek® and urine cytology in the detection of transitional cell carcinoma of the bladder.

May Al-Maghrebi1, Elijah O Kehinde, Kusum Kapila, Jehoram T Anim.   

Abstract

OBJECTIVE: To compare the diagnostic performance of urine cytology (UC), survivin mRNA expression, and the NMP22 BladderChek® (NMP22BC) test for the detection, grading and staging of transitional cell carcinoma (TCC) of the bladder.
MATERIALS AND METHODS: Voided urine samples collected from 25 healthy controls and 80 patients diagnosed with TCC of the bladder were subjected to UC, the NMP22BC test and reverse-transcription real-time PCR for survivin mRNA expression.
RESULTS: Survivin mRNA expression showed the highest sensitivity (87.5%) followed by the NMP22BC test (61.3%) while UC exhibited the lowest sensitivity (40%). All three urine markers had a similar specificity of 96% (95% CI 80.5-99.3%). Survivin mRNA expression was the only urine marker that showed a significant difference in relation to tumour histological grade (χ(2) 8.5, p = 0.015). None of the three urine markers was significantly related to tumour pathological stages.
CONCLUSION: The diagnostic sensitivity of urinary survivin mRNA expression was superior to that of UC and the NMP22BC test and correlates with tumour pathological grade but not stage.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22236881     DOI: 10.1159/000334811

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  6 in total

Review 1.  [Urine cytology - update 2013. A systematic review of recent literature].

Authors:  M Böhm; F vom Dorp; M Schostak; O W Hakenberg
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

2.  Diagnostic value of urinary survivin as a biomarker for bladder cancer: a systematic review and meta-analysis of published studies.

Authors:  Zhenzhen Liang; Rui Xin; Yinghui Yu; Rui Wang; Chunpeng Wang; Xin Liu
Journal:  World J Urol       Date:  2018-04-02       Impact factor: 4.226

3.  Diagnostic and prognostic value of bladder cancer-related transcript markers in urine.

Authors:  Juliane Schmidt; Catharina Propping; Woei-Yun Siow; Andrea Lohse-Fischer; Marieta Toma; Anka Baldauf-Twelker; Oliver W Hakenberg; Manfred P Wirth; Susanne Fuessel
Journal:  J Cancer Res Clin Oncol       Date:  2015-09-02       Impact factor: 4.553

4.  Inhibition of murine bladder cancer cell growth in vitro by photocontrollable siRNA based on upconversion fluorescent nanoparticles.

Authors:  Huichen Guo; Dan Yan; Yanquan Wei; Shichong Han; Haisheng Qian; Yunshang Yang; Yingpeng Zhang; Xiangtao Liu; Shiqi Sun
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

5.  Diagnostic accuracy of urinary survivin mRNA expression detected by RT-PCR compared with urine cytology in the detection of bladder cancer: A meta-analysis of diagnostic test accuracy in head-to-head studies.

Authors:  Liang Fu; Jiwang Zhang; Ling Li; Yuxing Yang; Yongqiang Yuan
Journal:  Oncol Lett       Date:  2019-12-18       Impact factor: 2.967

6.  Evaluation of the NMP22 BladderChek test for detecting bladder cancer: a systematic review and meta-analysis.

Authors:  Zijie Wang; Hongliang Que; Chuanjian Suo; Zhijian Han; Jun Tao; Zhengkai Huang; Xiaobin Ju; Ruoyun Tan; Min Gu
Journal:  Oncotarget       Date:  2017-10-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.